Showing results (21-30 of 94) with videos related to
Sort By:
Pageof 10
Plos One|August 12, 2017
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancerChristina Siesing, Halfdan Sorbye, Anca Dragomir, et al.Current Oncology Reports|August 22, 2023
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line TreatmentNikolaos Andreatos, Patrick W McGarrah, Mohamad Bassam Sonbol, et al.Cancer Treatment and Research Communications|February 3, 2022
Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancerPhilip Falk, Mira Severin, Åke Berglund, et al.Acta Oncologica (Stockholm, Sweden)|May 17, 2016
Experience with S-1 in older Caucasian patients with metastatic colorectal cancer (mCRC): Findings from an observational chart reviewStine Braendegaard Winther, Kanita Zubcevic, Camilla Qvortrup, et al.Acta Oncologica (Stockholm, Sweden)|November 27, 2019
Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian studyArtur Mezheyeuski, Fredrik Ponten, Per-Henrik Edqvist, et al.Frontiers in Oncology|March 3, 2020
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated SubgroupKristine Aasebø, Anca Dragomir, Magnus Sundström, et al.Endocrine-Related Cancer|July 13, 2026
Origin and evolution of colorectal mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)Siren Morken, Halfdan Sorbye, Wei Deng, et al.Journal of Neuroendocrinology|July 13, 2022
Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumorsEspen Thiis-Evensen, Magnus Kjellman, Ulrich Knigge, et al.Neuroendocrinology|October 3, 2019
Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine TumorsGitte Dam, Henning Grønbæk, Halfdan Sorbye, et al.British Journal of Cancer|October 21, 2021
Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patientsKristine Aasebø, Jarle Bruun, Christian H Bergsland, et al.Pageof 10